The Patent Finder

Novactyl, Inc.

Also on record
Records under this name other than patents Novactyl, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Novactyl, Inc.

PatentTitleStatus Expires Confidence
US 6,127,393Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
Formerly held
Term ended
Term ended Aug 1, 2018 · From the USPTO record
Term endedTerm ended Aug 1, 2018From the USPTO record
US 6,410,570Methods of inactivating a virus and controlling viral replication
Formerly held
Lapsed on the fee record
Ended Jun 25, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 25, 2014From the USPTO record
US 6,407,125Pharmacological agent and method of treatment
Formerly held
Lapsed on the fee record
Ended Jun 18, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 18, 2014From the USPTO record
US 6,743,771Methods and compositions for controlling protein assembly or aggregation
Formerly held
Lapsed on the fee record
Ended Jun 1, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 1, 2012From the USPTO record
US 6,939,884Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof
Lapsed on the fee record
Ended Sep 6, 2009 · From the USPTO record
Lapsed on the fee recordEnded Sep 6, 2009From the USPTO record
US 6,579,891Agent and method for prevention and treatment of cancer in animals
Lapsed on the fee record
Ended Jun 17, 2007 · From the USPTO record
Lapsed on the fee recordEnded Jun 17, 2007From the USPTO record
US 6,569,864Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof
Lapsed on the fee record
Ended May 27, 2007 · From the USPTO record
Lapsed on the fee recordEnded May 27, 2007From the USPTO record
US 6,441,009Agent and method of preventing and treating heavy metal exposure and toxicity
Formerly held
Lapsed on the fee record
Ended Aug 27, 2006 · From the USPTO record
Lapsed on the fee recordEnded Aug 27, 2006From the USPTO record
US 6,403,618Agent and method for controlling angiogenesis
Lapsed on the fee record
Ended Jun 11, 2006 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2006From the USPTO record
US 5,767,135Antiviral agent
Formerly held
Term ended
Term ended no later than Jun 16, 2018 · Low confidence
Term endedTerm ended no later than Jun 16, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited